Findings from a Dartmouth-led study published in the journal Science Translational Medicine, are offering new insights into neonatal herpes, its impact on developing nervous systems, and how newborns can be protected from the disease. In this innovative study, investigators were able to measure not only mortality but also neurological consequences of infection in mice who acquired the virus.
Post Tagged with: "David Leib"
David A. Leib, PhD, has been named the Chair of the Department of Microbiology and Immunology at Dartmouth’s Geisel School of Medicine. Since joining Dartmouth in 2009, Leib has built a successful research program focusing on discovery and elucidation of new vaccines and therapeutics for neonatal herpesvirus infections. In addition to his research efforts, Leib also teaches undergraduate and graduate courses in virology at Dartmouth.
A team of Dartmouth researchers has found that mothers who have developed antibodies against the herpes simplex virus (HSV-1) can pass these antibodies to the nervous systems of their infants, protecting them from acquiring the virus.